VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
XERS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
XERSXeris Biopharma Holdings, Inc.
$9.25$1.6B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksXERSPrice History

XERS logoXeris Biopharma Holdings, Inc. (XERS) Stock Price History

Historical prices from 2018 to 2026

$9.08-0.17  (-1.84%)close Oct 2
Returns
1M
+5.8%
3M
+9.7%
YTD
+23.5%
1Y
+9.3%
3Y
+73.1%
5Y
+30.6%
ATH$27.98Sep 2018-67.5%
ATL$0.97Jan 2023pre-split
Avg Vol (50D)2.1M/ day
52-Week Range$5.25 — $11.33
LowCurrent: $9.08High

Loading 10-year price history...

XERS Historical Performance

1 YearTotal Return
+9.3%
Price: +9.3%
3 YearsTotal Return
+418.9%
CAGR: +73.1%
Price: +418.9%
5 YearsTotal Return
+279.9%
CAGR: +30.6%
Price: +279.9%
YTD
+23.5%

XERS Annual Returns

Year-by-year price performance · 2018–2026

Best+126.9%2025
Worst-59.7%2019
Up years4/9
2018-15.9%
2019-59.7%
2020-26.6%
2021-44.8%
2022-52.7%
2023+109.8%
2024+49.3%
2025+126.9%
2026+9.9%
2018 annual price return
-15.9%
2019 annual price return
-59.7%
2020 annual price return
-26.6%
2021 annual price return
-44.8%
2022 annual price return
-52.7%
2023 annual price return
+109.8%
2024 annual price return
+49.3%
2025 annual price return
+126.9%
2026 annual price return
+9.9%
LessMore
Alpha vs S&P 500
1Y-5.7%
3Y+52.5%
5Y+17.8%

Price returns only.

Download Historical Data

2,082 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

XERS Stock Price Trajectory (2018–2026)

As of October 3, 2026, Xeris Biopharma Holdings, Inc. (XERS) trades at $9.08, representing a +9.3% return over the past year. The stock has delivered a +279.9% total return over five years (+30.6% CAGR), reflecting significant long-term value creation.

The stock reached its all-time high of $27.98 on September 12, 2018. From this peak, XERS has corrected -67.5%, currently trading 26% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers LNTH (+89.7% 1Y), SUPN (-11.6% 1Y), and PAHC (-4.5% 1Y), XERS has underperformed the peer group average. Compare XERS vs LNTH →

XERS Historical Price Data · from 2018

Rows 1–50 of 2,082
Date Open High Low Close Volume Change %
2026-10-029.349.349.049.081.38M-1.84%
2026-10-019.549.699.189.252.92M-3.24%
2026-09-309.9610.079.549.562.94M-4.21%
2026-09-299.7711.339.509.9819.19M+1.53%
2026-09-289.0510.019.009.833.46M+8.02%
2026-09-258.979.158.859.101.55M+1.68%
2026-09-248.658.998.568.951.35M+3.35%
2026-09-238.749.208.468.662.04M-0.80%
2026-09-228.888.978.648.731.69M-0.80%
2026-09-218.648.818.468.802.44M+7.32%
2026-09-188.138.257.938.203.86M+0.49%
2026-09-177.898.187.728.162.34M+4.88%
2026-09-167.547.927.507.782.03M+3.87%
2026-09-157.577.587.417.491.18M-1.06%
2026-09-147.587.697.527.571.27M+1.61%
2026-09-117.867.897.407.451.59M-2.87%
2026-09-107.808.007.637.671.95M-0.52%
2026-09-098.438.617.647.712.72M-9.08%
2026-09-088.408.528.228.481.25M-0.59%
2026-09-048.508.598.388.531.03M-0.70%
2026-09-038.658.788.418.591.54M+0.12%
2026-09-028.498.638.278.581.35M+1.78%
2026-09-018.428.628.388.431.14M-0.12%
2026-08-318.458.488.298.441.34M-0.47%
2026-08-288.618.688.388.481.03M-1.40%
2026-08-278.628.758.558.601.26M-0.92%
2026-08-268.748.898.618.681.50M-0.69%
2026-08-258.818.948.748.74961K0.00%
2026-08-248.668.808.548.74871K+0.46%
2026-08-218.618.818.548.701.56M+1.16%
2026-08-208.918.998.568.602.00M-2.05%
2026-08-198.939.028.778.782.25M-0.79%
2026-08-188.588.888.478.852.14M+3.87%
2026-08-178.458.558.268.521.33M-0.93%
2026-08-148.338.678.258.601.37M+3.24%
2026-08-138.598.708.308.331.85M-1.88%
2026-08-128.378.528.248.491.73M+1.19%
2026-08-118.008.447.968.391.78M+5.01%
2026-08-107.968.077.807.991.62M+0.76%
2026-08-077.438.027.437.932.25M+7.74%
2026-08-067.197.447.057.363.72M-9.25%
2026-08-058.218.378.068.111.75M-0.98%
2026-08-048.138.288.048.191.84M+0.74%
2026-08-038.148.177.878.131.95M+0.62%
2026-07-318.348.407.998.081.62M-4.04%
2026-07-308.388.468.328.42921K+0.48%
2026-07-298.238.498.238.381.19M+1.70%
2026-07-288.288.338.138.24812K+0.37%
2026-07-278.408.478.208.21873K-1.32%
2026-07-248.428.548.298.321.18M-1.07%
…
Consensus & Technical Research Suite
Open XERS Terminal

XERS Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

XERS — Frequently Asked Questions

Quick answers to the most common questions about buying XERS stock.

How has XERS stock performed recently?

XERS returned +9.3% over the past year, beating its 5-year annualized CAGR of +30.6%. The stock trades above its 200-day moving average, confirming the uptrend.

What is XERS's all-time high price?

Xeris Biopharma Holdings, Inc. reached $27.98 on 2018-09-12. The 52-week high is $11.33. Current 1-year return of +9.3% places the stock closer to historical peaks.

Where can I download XERS historical price data?

This page provides XERS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2018-2026, downloadable in CSV format.

418 data points · sampled from 2,082